TY - JOUR
T1 - Nuclear β-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma
AU - Saito, Tsuyoshi
AU - Oda, Yoshinao
AU - Yamamoto, Hidetaka
AU - Kawaguchi, Ken ichi
AU - Tanaka, Kazuhiro
AU - Matsuda, Shuichi
AU - Iwamoto, Yukihide
AU - Tsuneyoshi, Masazumi
PY - 2006/6
Y1 - 2006/6
N2 - Nuclear β-catenin staining in soft tissue sarcomas (STSs) has been shown to correlate with tumor progression as assessed by proliferative activity or poor prognosis. Frequent activation of Wnt signaling pathway has been also shown in synovial sarcoma (SS), suggesting a specific role of this pathway in SS. We examined roles of nuclear β-catenin staining within soft tissue sarcomas. Immunohistochemical detection of nuclear β-catenin accumulation correlated with cyclin D1 overexpression in spindle cell and pleomorphic sarcomas (P = .037), and the expression of these proteins evenly distributed throughout each section. In some cases, strong β-catenin nuclear staining was observed in highly pleomorphic and mitotic cells. Furthermore, tumors with nuclear β-catenin accumulation showed statistically significant increasing cyclin D1 mRNA expression level compared with those without (P = .023). Cyclin D1 mRNA expression levels were statistically higher in tumors with cyclin D1 overexpression than in tumors without (P = .037), suggesting that cyclin D1 overexpression is due to transcriptional activation. However, these correlations could not be detected in SS. In biphasic SS, β-catenin nuclear staining was observed in spindle cells, whereas cyclin D1 nuclear staining was seen in glandular areas where β-catenin kept membranous expression. Mutations in exon 3 of the β-catenin gene and in the mutation cluster region of adenomatous polyposis coli gene were absent in this series of cases. Thus, cyclin D1 could be considered as one of the targets of the nuclear β-catenin in spindle cell and pleomorphic sarcomas. A possible association between β-catenin accumulation and spindle cell morphogenesis may exist in SS.
AB - Nuclear β-catenin staining in soft tissue sarcomas (STSs) has been shown to correlate with tumor progression as assessed by proliferative activity or poor prognosis. Frequent activation of Wnt signaling pathway has been also shown in synovial sarcoma (SS), suggesting a specific role of this pathway in SS. We examined roles of nuclear β-catenin staining within soft tissue sarcomas. Immunohistochemical detection of nuclear β-catenin accumulation correlated with cyclin D1 overexpression in spindle cell and pleomorphic sarcomas (P = .037), and the expression of these proteins evenly distributed throughout each section. In some cases, strong β-catenin nuclear staining was observed in highly pleomorphic and mitotic cells. Furthermore, tumors with nuclear β-catenin accumulation showed statistically significant increasing cyclin D1 mRNA expression level compared with those without (P = .023). Cyclin D1 mRNA expression levels were statistically higher in tumors with cyclin D1 overexpression than in tumors without (P = .037), suggesting that cyclin D1 overexpression is due to transcriptional activation. However, these correlations could not be detected in SS. In biphasic SS, β-catenin nuclear staining was observed in spindle cells, whereas cyclin D1 nuclear staining was seen in glandular areas where β-catenin kept membranous expression. Mutations in exon 3 of the β-catenin gene and in the mutation cluster region of adenomatous polyposis coli gene were absent in this series of cases. Thus, cyclin D1 could be considered as one of the targets of the nuclear β-catenin in spindle cell and pleomorphic sarcomas. A possible association between β-catenin accumulation and spindle cell morphogenesis may exist in SS.
UR - http://www.scopus.com/inward/record.url?scp=33745454527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745454527&partnerID=8YFLogxK
U2 - 10.1016/j.humpath.2006.01.017
DO - 10.1016/j.humpath.2006.01.017
M3 - Article
C2 - 16733209
AN - SCOPUS:33745454527
SN - 0046-8177
VL - 37
SP - 689
EP - 697
JO - Human Pathology
JF - Human Pathology
IS - 6
ER -